Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in a deal worth up to $18.3 billion, it said on Tuesday, marking one of the largest healthcare take-private transactions this ...
In one of the biggest healthcare acquisitions of its kind this year, medtech diagnostics specialist Hologic will go private following its sale to Blackstone and TPG in a deal valued at more than $18.3 ...
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic’s Closing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Hologic (Nasdaq: HOLX) said this ...
Hologic’s HOLX GYN Surgical business is benefiting from a mix of internal innovation and product line additions through M&A, ...
The latest update on Hologic centers on a very slight trim to the fair value estimate, from about US$76.50 to about US$76.42 per share. This keeps it closely aligned with the proposed acquisition ...
-- Transaction Further Diversifies Hologic’s Product Offering and Broadens Access to Bolder Devices-- MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's ...
The market awaits Hologic's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to ...
Zacks Investment Research on MSN
Hologic Q1 earnings preview: How should you play the stock now?
Hologic HOLX is set to release first-quarter fiscal 2026 results on Jan. 29, after the closing bell. The Zacks Consensus ...
10 analysts have shared their evaluations of Hologic (NASDAQ:HOLX) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...
Across the recent three months, 11 analysts have shared their insights on Hologic (NASDAQ:HOLX), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed ...
The company’s technology ranges from a commercial 3D mammography system to testing for cervical cancer, sexually transmitted infections and respiratory illnesses. From the Boston Business Journal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results